Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8601 |
High Similarity |
NPD4499 |
Approved |
0.8204 |
Intermediate Similarity |
NPD2916 |
Discontinued |
0.8079 |
Intermediate Similarity |
NPD4118 |
Clinical (unspecified phase) |
0.7974 |
Intermediate Similarity |
NPD8358 |
Approved |
0.7864 |
Intermediate Similarity |
NPD484 |
Approved |
0.7864 |
Intermediate Similarity |
NPD4601 |
Approved |
0.7864 |
Intermediate Similarity |
NPD4600 |
Approved |
0.7782 |
Intermediate Similarity |
NPD8364 |
Approved |
0.7782 |
Intermediate Similarity |
NPD8363 |
Approved |
0.7778 |
Intermediate Similarity |
NPD8405 |
Clinical (unspecified phase) |
0.7773 |
Intermediate Similarity |
NPD6376 |
Discontinued |
0.7718 |
Intermediate Similarity |
NPD8365 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD5901 |
Discontinued |
0.7689 |
Intermediate Similarity |
NPD5658 |
Approved |
0.7681 |
Intermediate Similarity |
NPD4987 |
Clinical (unspecified phase) |
0.7636 |
Intermediate Similarity |
NPD6824 |
Clinical (unspecified phase) |
0.7633 |
Intermediate Similarity |
NPD5003 |
Discontinued |
0.7633 |
Intermediate Similarity |
NPD7948 |
Phase 1 |
0.7592 |
Intermediate Similarity |
NPD8467 |
Approved |
0.7592 |
Intermediate Similarity |
NPD8466 |
Approved |
0.7592 |
Intermediate Similarity |
NPD8465 |
Approved |
0.7586 |
Intermediate Similarity |
NPD4948 |
Discontinued |
0.7571 |
Intermediate Similarity |
NPD4511 |
Phase 1 |
0.7561 |
Intermediate Similarity |
NPD6630 |
Clinical (unspecified phase) |
0.7558 |
Intermediate Similarity |
NPD5417 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD1326 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1325 |
Approved |
0.7534 |
Intermediate Similarity |
NPD7603 |
Discontinued |
0.7534 |
Intermediate Similarity |
NPD5632 |
Approved |
0.7524 |
Intermediate Similarity |
NPD4501 |
Approved |
0.7524 |
Intermediate Similarity |
NPD4500 |
Approved |
0.75 |
Intermediate Similarity |
NPD2844 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD5512 |
Phase 3 |
0.7488 |
Intermediate Similarity |
NPD5575 |
Clinical (unspecified phase) |
0.7488 |
Intermediate Similarity |
NPD6344 |
Clinical (unspecified phase) |
0.7478 |
Intermediate Similarity |
NPD8016 |
Phase 3 |
0.7478 |
Intermediate Similarity |
NPD8017 |
Clinical (unspecified phase) |
0.7475 |
Intermediate Similarity |
NPD5522 |
Clinical (unspecified phase) |
0.747 |
Intermediate Similarity |
NPD8460 |
Approved |
0.747 |
Intermediate Similarity |
NPD8459 |
Approved |
0.747 |
Intermediate Similarity |
NPD8426 |
Approved |
0.747 |
Intermediate Similarity |
NPD8425 |
Approved |
0.7449 |
Intermediate Similarity |
NPD8428 |
Approved |
0.7449 |
Intermediate Similarity |
NPD8427 |
Approved |
0.7449 |
Intermediate Similarity |
NPD8429 |
Approved |
0.7445 |
Intermediate Similarity |
NPD4885 |
Approved |
0.743 |
Intermediate Similarity |
NPD4862 |
Clinical (unspecified phase) |
0.743 |
Intermediate Similarity |
NPD3003 |
Approved |
0.7419 |
Intermediate Similarity |
NPD7470 |
Discontinued |
0.7393 |
Intermediate Similarity |
NPD3814 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7955 |
Approved |
0.7375 |
Intermediate Similarity |
NPD7956 |
Approved |
0.7371 |
Intermediate Similarity |
NPD5721 |
Clinical (unspecified phase) |
0.7352 |
Intermediate Similarity |
NPD3243 |
Approved |
0.735 |
Intermediate Similarity |
NPD5065 |
Approved |
0.7345 |
Intermediate Similarity |
NPD3259 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2564 |
Approved |
0.7343 |
Intermediate Similarity |
NPD2565 |
Phase 2 |
0.7336 |
Intermediate Similarity |
NPD6176 |
Phase 1 |
0.733 |
Intermediate Similarity |
NPD2383 |
Phase 1 |
0.7328 |
Intermediate Similarity |
NPD2921 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD6160 |
Clinical (unspecified phase) |
0.7321 |
Intermediate Similarity |
NPD802 |
Phase 2 |
0.7315 |
Intermediate Similarity |
NPD7453 |
Approved |
0.7315 |
Intermediate Similarity |
NPD7452 |
Approved |
0.7306 |
Intermediate Similarity |
NPD6657 |
Clinical (unspecified phase) |
0.7304 |
Intermediate Similarity |
NPD5728 |
Clinical (unspecified phase) |
0.7295 |
Intermediate Similarity |
NPD7803 |
Approved |
0.7281 |
Intermediate Similarity |
NPD2509 |
Approved |
0.7281 |
Intermediate Similarity |
NPD2510 |
Approved |
0.7273 |
Intermediate Similarity |
NPD5937 |
Approved |
0.7264 |
Intermediate Similarity |
NPD482 |
Approved |
0.7261 |
Intermediate Similarity |
NPD4373 |
Phase 2 |
0.7261 |
Intermediate Similarity |
NPD5040 |
Clinical (unspecified phase) |
0.724 |
Intermediate Similarity |
NPD4897 |
Phase 2 |
0.7235 |
Intermediate Similarity |
NPD6838 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD5429 |
Discontinued |
0.7235 |
Intermediate Similarity |
NPD7222 |
Phase 2 |
0.7232 |
Intermediate Similarity |
NPD6242 |
Discontinued |
0.723 |
Intermediate Similarity |
NPD2175 |
Phase 3 |
0.723 |
Intermediate Similarity |
NPD6661 |
Clinical (unspecified phase) |
0.723 |
Intermediate Similarity |
NPD2177 |
Approved |
0.723 |
Intermediate Similarity |
NPD2176 |
Approved |
0.723 |
Intermediate Similarity |
NPD1768 |
Approved |
0.7228 |
Intermediate Similarity |
NPD749 |
Clinical (unspecified phase) |
0.7227 |
Intermediate Similarity |
NPD5482 |
Discontinued |
0.7227 |
Intermediate Similarity |
NPD3330 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD6790 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD5426 |
Phase 3 |
0.7222 |
Intermediate Similarity |
NPD6323 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD7417 |
Discontinued |
0.722 |
Intermediate Similarity |
NPD2092 |
Phase 2 |
0.722 |
Intermediate Similarity |
NPD7878 |
Phase 2 |
0.722 |
Intermediate Similarity |
NPD2095 |
Phase 2 |
0.722 |
Intermediate Similarity |
NPD2094 |
Phase 2 |
0.7207 |
Intermediate Similarity |
NPD3394 |
Approved |
0.7207 |
Intermediate Similarity |
NPD3393 |
Approved |
0.7207 |
Intermediate Similarity |
NPD3389 |
Approved |
0.7205 |
Intermediate Similarity |
NPD4952 |
Phase 3 |
0.7205 |
Intermediate Similarity |
NPD5801 |
Clinical (unspecified phase) |
0.7204 |
Intermediate Similarity |
NPD4602 |
Approved |
0.7204 |
Intermediate Similarity |
NPD4418 |
Discontinued |
0.7196 |
Intermediate Similarity |
NPD5497 |
Clinical (unspecified phase) |
0.7193 |
Intermediate Similarity |
NPD7268 |
Clinical (unspecified phase) |
0.7189 |
Intermediate Similarity |
NPD3932 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD7194 |
Discontinued |
0.7188 |
Intermediate Similarity |
NPD6770 |
Approved |
0.7184 |
Intermediate Similarity |
NPD2091 |
Phase 2 |
0.7184 |
Intermediate Similarity |
NPD2096 |
Phase 2 |
0.7183 |
Intermediate Similarity |
NPD7777 |
Approved |
0.7183 |
Intermediate Similarity |
NPD7778 |
Approved |
0.7183 |
Intermediate Similarity |
NPD53 |
Approved |
0.7182 |
Intermediate Similarity |
NPD5939 |
Approved |
0.7182 |
Intermediate Similarity |
NPD6567 |
Clinical (unspecified phase) |
0.7182 |
Intermediate Similarity |
NPD5936 |
Approved |
0.7182 |
Intermediate Similarity |
NPD5416 |
Discontinued |
0.7176 |
Intermediate Similarity |
NPD2121 |
Clinical (unspecified phase) |
0.7175 |
Intermediate Similarity |
NPD7823 |
Clinical (unspecified phase) |
0.7174 |
Intermediate Similarity |
NPD6962 |
Phase 2 |
0.7163 |
Intermediate Similarity |
NPD6141 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD5903 |
Approved |
0.7162 |
Intermediate Similarity |
NPD5902 |
Approved |
0.7162 |
Intermediate Similarity |
NPD8112 |
Clinical (unspecified phase) |
0.7156 |
Intermediate Similarity |
NPD1038 |
Approved |
0.7155 |
Intermediate Similarity |
NPD3986 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD8489 |
Phase 1 |
0.7149 |
Intermediate Similarity |
NPD7069 |
Discontinued |
0.7143 |
Intermediate Similarity |
NPD3946 |
Clinical (unspecified phase) |
0.7136 |
Intermediate Similarity |
NPD5744 |
Clinical (unspecified phase) |
0.7131 |
Intermediate Similarity |
NPD7708 |
Approved |
0.7131 |
Intermediate Similarity |
NPD5483 |
Clinical (unspecified phase) |
0.713 |
Intermediate Similarity |
NPD6803 |
Clinical (unspecified phase) |
0.713 |
Intermediate Similarity |
NPD5612 |
Discontinued |
0.7129 |
Intermediate Similarity |
NPD750 |
Phase 2 |
0.7121 |
Intermediate Similarity |
NPD1685 |
Approved |
0.7121 |
Intermediate Similarity |
NPD1684 |
Approved |
0.7118 |
Intermediate Similarity |
NPD6292 |
Clinical (unspecified phase) |
0.7112 |
Intermediate Similarity |
NPD7558 |
Phase 2 |
0.7108 |
Intermediate Similarity |
NPD6159 |
Phase 2 |
0.7104 |
Intermediate Similarity |
NPD8013 |
Clinical (unspecified phase) |
0.7101 |
Intermediate Similarity |
NPD5488 |
Discontinued |
0.7091 |
Intermediate Similarity |
NPD4506 |
Discontinued |
0.7085 |
Intermediate Similarity |
NPD5293 |
Phase 2 |
0.7078 |
Intermediate Similarity |
NPD3930 |
Clinical (unspecified phase) |
0.707 |
Intermediate Similarity |
NPD8396 |
Approved |
0.707 |
Intermediate Similarity |
NPD8395 |
Approved |
0.7067 |
Intermediate Similarity |
NPD6985 |
Discontinued |
0.7067 |
Intermediate Similarity |
NPD7395 |
Discontinued |
0.7064 |
Intermediate Similarity |
NPD6138 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5912 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD5913 |
Phase 3 |
0.7053 |
Intermediate Similarity |
NPD5596 |
Phase 2 |
0.7049 |
Intermediate Similarity |
NPD8091 |
Phase 3 |
0.7048 |
Intermediate Similarity |
NPD5507 |
Approved |
0.7048 |
Intermediate Similarity |
NPD5506 |
Approved |
0.7048 |
Intermediate Similarity |
NPD1534 |
Approved |
0.7046 |
Intermediate Similarity |
NPD6517 |
Phase 3 |
0.7046 |
Intermediate Similarity |
NPD6716 |
Phase 1 |
0.7045 |
Intermediate Similarity |
NPD7947 |
Clinical (unspecified phase) |
0.7043 |
Intermediate Similarity |
NPD7994 |
Phase 2 |
0.7042 |
Intermediate Similarity |
NPD6861 |
Clinical (unspecified phase) |
0.7042 |
Intermediate Similarity |
NPD5975 |
Clinical (unspecified phase) |
0.7041 |
Intermediate Similarity |
NPD5257 |
Clinical (unspecified phase) |
0.704 |
Intermediate Similarity |
NPD8094 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD6452 |
Discontinued |
0.7039 |
Intermediate Similarity |
NPD5473 |
Discontinued |
0.7032 |
Intermediate Similarity |
NPD7958 |
Clinical (unspecified phase) |
0.7032 |
Intermediate Similarity |
NPD7957 |
Phase 1 |
0.7027 |
Intermediate Similarity |
NPD4502 |
Phase 2 |
0.7026 |
Intermediate Similarity |
NPD2882 |
Phase 1 |
0.7023 |
Intermediate Similarity |
NPD4397 |
Phase 1 |
0.7023 |
Intermediate Similarity |
NPD7889 |
Clinical (unspecified phase) |
0.7018 |
Intermediate Similarity |
NPD2920 |
Discontinued |
0.7015 |
Intermediate Similarity |
NPD4554 |
Clinical (unspecified phase) |
0.7009 |
Intermediate Similarity |
NPD7818 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD4203 |
Approved |
0.7005 |
Intermediate Similarity |
NPD4204 |
Approved |
0.7 |
Intermediate Similarity |
NPD1392 |
Approved |
0.7 |
Intermediate Similarity |
NPD6290 |
Phase 2 |
0.6996 |
Remote Similarity |
NPD8093 |
Discontinued |
0.6996 |
Remote Similarity |
NPD7594 |
Clinical (unspecified phase) |
0.6995 |
Remote Similarity |
NPD1304 |
Clinical (unspecified phase) |
0.6991 |
Remote Similarity |
NPD6999 |
Discontinued |
0.6991 |
Remote Similarity |
NPD3354 |
Phase 2 |
0.6991 |
Remote Similarity |
NPD7000 |
Clinical (unspecified phase) |
0.6991 |
Remote Similarity |
NPD8109 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD6987 |
Phase 1 |
0.6986 |
Remote Similarity |
NPD3947 |
Discontinued |
0.6986 |
Remote Similarity |
NPD6610 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD8098 |
Approved |
0.6983 |
Remote Similarity |
NPD6503 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD648 |
Clinical (unspecified phase) |
0.6982 |
Remote Similarity |
NPD7998 |
Clinical (unspecified phase) |
0.6981 |
Remote Similarity |
NPD5592 |
Clinical (unspecified phase) |
0.698 |
Remote Similarity |
NPD7181 |
Phase 3 |
0.6979 |
Remote Similarity |
NPD7853 |
Phase 2 |
0.697 |
Remote Similarity |
NPD4845 |
Discontinued |
0.6967 |
Remote Similarity |
NPD4334 |
Discontinued |
0.6964 |
Remote Similarity |
NPD7571 |
Clinical (unspecified phase) |
0.6963
|
Remote Similarity |
NPD7618 |
Phase 3 |